Medicare Negotiation Round Two Will Be Dominated By Oral Cancer Drugs, Researchers Predict

 
• By Cathy Kelly
  
Round 2
Focus On Cancer Agents May Fuel Opposition To Timeline For Small Molecule Drugs • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Medicare

More from Government Payers